Wenchong Ye

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Synthesis and Biological Evaluation of C6-O-Glycosylated α-Mangostin Derivatives Against Methicillin-Resistant Staphylococcus aureus With Enhanced Bacterial Membrane Selectivity.

Synthesis and Biological Evaluation of C6-O-Glycosylated α-Mangostin Derivatives Against Methicillin-Resistant Staphylococcus aureus With Enhanced Bacterial Membrane Selectivity.

Journal: ChemMedChem

Published: March 09, 2026

Discovery of 2-phenylethyl chromones as potent and selective CYP1B1 inhibitors.

Discovery of 2-phenylethyl chromones as potent and selective CYP1B1 inhibitors.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: January 02, 2026

Antibiotic Resistance of Escherichia coli and Klebsiella pneumoniae Isolated from Wild Raccoon Dogs in Shanghai, China.

Antibiotic Resistance of Escherichia coli and Klebsiella pneumoniae Isolated from Wild Raccoon Dogs in Shanghai, China.

Journal: Microbial drug resistance (Larchmont, N.Y.)

Published: November 03, 2025

Macrocyclic Compounds: Unveiling Their Distinctive Antiviral Advantages in Medicinal Research.

Macrocyclic Compounds: Unveiling Their Distinctive Antiviral Advantages in Medicinal Research.

Journal: Journal of medicinal chemistry

Published: October 10, 2025

Traditional Chinese Medicine: Dual Antibacterial Actions via Host Defense Balance and Bacterial Inhibition.

Traditional Chinese Medicine: Dual Antibacterial Actions via Host Defense Balance and Bacterial Inhibition.

Journal: Phytotherapy research : PTR

Published: August 27, 2025

PRKAG1 mediates the anti-Japanese encephalitis virus effect of Nitazoxanide through autophagy.

PRKAG1 mediates the anti-Japanese encephalitis virus effect of Nitazoxanide through autophagy.

Journal: Veterinary microbiology

Published: July 28, 2025

Corrigendum to "Discovery of 3,4-dihydropyrimidine derivatives as novel Anti-PEDV agents targeting viral internalization through a unique calcium homeostasis disruption mechanism" [Europ. J. Med. Chem. 291 (2025) 117637].

Corrigendum to "Discovery of 3,4-dihydropyrimidine derivatives as novel Anti-PEDV agents targeting viral internalization through a unique calcium homeostasis disruption mechanism" [Europ. J. Med. Chem. 291 (2025) 117637].

Journal: European journal of medicinal chemistry

Published: May 01, 2025

Nitazoxanide potentiates polymyxin B against Escherichia coli by inhibiting energy metabolism enzymes.

Nitazoxanide potentiates polymyxin B against Escherichia coli by inhibiting energy metabolism enzymes.

Journal: Microbial pathogenesis

Published: March 10, 2025

Discovery of 3,4-dihydropyrimidine derivatives as novel Anti-PEDV agents targeting viral internalization through a unique calcium homeostasis disruption mechanism.

Discovery of 3,4-dihydropyrimidine derivatives as novel Anti-PEDV agents targeting viral internalization through a unique calcium homeostasis disruption mechanism.

Journal: European journal of medicinal chemistry

Published: February 14, 2025

A novel α-mangostin derivative synergistic to antibiotics against MRSA with unique mechanisms.

A novel α-mangostin derivative synergistic to antibiotics against MRSA with unique mechanisms.

Journal: Microbiology spectrum

Published: November 07, 2024

Discovery of xanthone-based nitric oxide donors targeting biofilm clearance.

Discovery of xanthone-based nitric oxide donors targeting biofilm clearance.

Journal: Archiv der Pharmazie

Published: October 07, 2024

Synthesis and evaluation of novel tetrahydroisoquinoline-benzo[h]chromen-4-one conjugates as dual ABCB1/CYP1B1 inhibitors for overcoming MDR in cancer.

Synthesis and evaluation of novel tetrahydroisoquinoline-benzo[h]chromen-4-one conjugates as dual ABCB1/CYP1B1 inhibitors for overcoming MDR in cancer.

Journal: Bioorganic & medicinal chemistry

Published: July 01, 2024

Showing 1-12 of 16

Last Updated: 09/26/2026